Navigation Links
Microspeed EC

ProductsMicrospeed EC
Company AESCULAP
Item Microspeed EC
Features 
  • high and low speed capabilities in one system
  • new control system reduces heating at high running speeds
  • large range of eronomically designed handpieces
  • simple lubrication
  • quick connect components
  • compatible to HiLan XS and Elan EC handpieces
  • complete line of burrs and blades
  • Description Electric high speed system.
    Info AESCULAP
    Customer Service: (800) 282-9000
    Web site: http://www.aesculapusa.com/

    Related medicine products :

    1. SphygmoCor Px Central Blood Pressure Assessment and Management System
    2. SphygmoCor Mx Central Blood Pressure Monitoring System
    3. SphygmoCor Px Pulse Wave Analysis System test
    4. Innotrac Aio! Central
    5. Endoalpha Centralized O.R. Control System
    6. Centralized Holter Analysis
    7. S/5 iCentral
    8. Acuity LT Central Station
    9. Mobile Acuity LT™ Central Station
    10. Acuity® Central Station
    11. Oxinet III Central Station Network
    1.0 mm long 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
    0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
    Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
    Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
    Medicine Products:
    (Date:12/6/2009)... study provides welcome news for patients with a common ... The condition is estimated to impact 62,000 Canadians and ... clot forms in a vein and restricts the flow ... the clot may detach from its point of origin ... a potentially fatal condition known as a pulmonary embolism. ...
    (Date:12/6/2009)... W. Belluck of Belluck & Fox, LLP says dangerous substances such ... , ... New York, NY (PRWEB) December 6, 2009 ... they should be alert to reports of recalls due to lead ... , ,“Close to 230,000 children visit hospital emergency rooms each year ...
    (Date:12/5/2009)... ,, What: Cuts for a Cause ... the fight against cancer and other terminal illnesses affecting children. ... to St. Jude Children,s Research Hospital. Guests will enjoy complimentary ... and savory Vietnamese restaurant in Falls Church for all guests. ...
    (Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
    (Date:12/5/2009)... helps companies develop and test their cleaning processes. The technology available ... industries and solve problems for customers relating to cleaning parts, process ... ... -- Midbrook, Inc , a Jackson, MI-based company, is home ...
    Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
    ... Sciences LLC,has been notified by the Mississippi and Tennessee ... to a Section 18,label for Avitec. Avitec protects corn ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080421/AQM109 ), Bird damage to ... from the soil to eat the remains of the ...
    ... April 21 Lincare Holdings,Inc. (Nasdaq: LNCR ), ... delivered to patients in the home, today announced,financial results ... For the quarter ended March 31, 2008, revenues were ... for the first quarter of 2007.,The Company estimates that ...
    ... tray saves water and energy; reduces food waste, GAITHERSBURG, ... campuses served by Sodexo will line up to get their ... The move was introduced by Sodexo,as part of the company,s ... thousands of gallons of water each day,and reduces electricity and ...
    ... Inc. (Nasdaq: ISTA ), today announced it will ... after the U.S. markets,close. ISTA will host a conference ... 4:30 p.m. Eastern Time on April 30., To ... may,dial 866-362-5158; international participants may dial 617-597-5397. The,access code ...
    ... Association issues new guidelines in response to growing ... (HealthDay News) -- The American Heart Association on ... before prescribing stimulant treatment for all children diagnosed ... are meant to address mounting fears that these ...
    ... appear more likely to be melanomas than smaller lesions, ... Archives of Dermatology, one of the JAMA/Archives journals. The ... dermatologists to screen for melanoma are useful. , Many ... according to background information in the article. The criteria ...
    Other Medicine News:Health News:Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment 2Health News:Lincare Holdings Inc. Announces First Quarter 2008 Financial Results 2Health News:Lincare Holdings Inc. Announces First Quarter 2008 Financial Results 3Health News:Lincare Holdings Inc. Announces First Quarter 2008 Financial Results 4Health News:Lincare Holdings Inc. Announces First Quarter 2008 Financial Results 5Health News:Sodexo Challenges Diners on College Campuses to Go Trayless and Go Green 2Health News:Cardiac Screening Recommended for Kids Taking Stimulants for ADHD 2Health News:Cardiac Screening Recommended for Kids Taking Stimulants for ADHD 3Health News:Cardiac Screening Recommended for Kids Taking Stimulants for ADHD 4Health News:Larger skin lesions appear more likely to be melanomas 2
    (Date:12/4/2009)... BETHESDA, Md., Dec. 4 Drs. Neal Shore and ... recurrence from the additional analysis of secondary end points ... study of FIRMAGON® (monthly degarelix for injection) or monthly ... of treatment. Prostate cancer patients who received FIRMAGON ...
    (Date:12/3/2009)... Dec. 3 Allen Medical Systems, a subsidiary of ... announced the launch of its new Allen Amatech(TM) OEM ... ,, The website reinforces the Allen Amatech(TM) ... new product catalog, with detailed descriptions and design specifications ...
    (Date:12/3/2009)... BioMed Realty Trust, Inc. (NYSE: BMR ) ... with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately ... at The Landmark at Eastview campus in Tarrytown, New York. ... of additional space was completed approximately two months after BioMed ...
    Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Switching on the power of stem cells 9639 1Switching on the power of stem cells 9639 2A new bent on fusion 9637 1A new bent on fusion 9637 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3